Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 30, 2021 - Issue 9
Submit an article Journal homepage
465
Views
6
CrossRef citations to date
0
Altmetric
Review

Immune checkpoint inhibitors for the treatment of myeloma: novel investigational options

Baptiste Le Calveza Department of Hematology, Centre Hospitalier Universitaire, Nantes, FranceView further author information
,
Philippe Moreaua Department of Hematology, Centre Hospitalier Universitaire, Nantes, France;b CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, France;c Site de Recherche Intégrée sur le Cancer (SIRIC) « ILIAD », Nantes, FranceView further author information
&
Cyrille Touzeaua Department of Hematology, Centre Hospitalier Universitaire, Nantes, France;b CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, France;c Site de Recherche Intégrée sur le Cancer (SIRIC) « ILIAD », Nantes, FranceCorrespondence[email protected]
View further author information
Pages 965-973 | Received 31 Mar 2021, Accepted 09 Jul 2021, Published online: 19 Jul 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Massimo Offidani, Laura Corvatta, Sonia Morè, Maria Valentina Manieri & Attilio Olivieri. (2022) An update on novel multiple myeloma targets. Expert Review of Hematology 15:6, pages 519-537.
Read now
Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta-Caldarola & Gennaro Palmiotti. (2022) Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology 16:4, pages 333-339.
Read now
Alessandro Rizzo & Angela Dalia Ricci. (2022) Predictors of response for hepatocellular carcinoma immunotherapy: is there anything on the horizon?. Expert Review of Precision Medicine and Drug Development 7:1, pages 50-57.
Read now

Articles from other publishers (3)

Weam Othman Elbezanti, Kishore B. Challagundla, Subash C. Jonnalagadda, Tulin Budak-Alpdogan & Manoj K. Pandey. (2023) Past, Present, and a Glance into the Future of Multiple Myeloma Treatment. Pharmaceuticals 16:3, pages 415.
Crossref
Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, Francesca Gay & Mattia D’Agostino. (2022) Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?. International Journal of Molecular Sciences 23:24, pages 15879.
Crossref
Rosario Hervás-Salcedo & Beatriz Martín-Antonio. (2022) A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments. Cancers 14:15, pages 3796.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.